JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2007;60:1065-1066; doi:10.1136/jcp.2006.036988
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Twomey, P J
Right arrow Articles by Pledger, D R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Twomey, P J
Right arrow Articles by Pledger, D R
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

SHORT REPORT

HDL-cholesterol and triglycerides: an overlooked issue?

P J Twomey, D R Pledger

Department of Clinical Biochemistry, The Ipswich Hospital, Heath Road, Ipswich, Suffolk IP4 5PD, UK

Correspondence to:
Dr Patrick J Twomey
Department of Clinical Biochemistry, The Ipswich Hospital, Heath Road, Ipswich, Suffolk IP4 5PD, UK; patrick.twomey@ipswichhospital.nhs.uk 31 January 2006

Keywords: CHD risk; HDL-C; accuracy; total error; tryglycerides

The first 150 words of the full text of this article appear below.

Several prospective clinical trials and epidemiological studies have shown that a low concentration of high-density lipoprotein-cholesterol (HDL-C) is an independent risk factor for coronary heart disease (CHD).1,2 It is estimated that for every 0.0259 mmol/l decrease in HDL-C, the relative risk of CHD events increases by 2–3%.3 Accordingly, HDL-C determinations are included in CHD prevention programmes.4 Reliable and easy to perform HDL-C assays are therefore required for routine laboratory practice.

There is often an inverse relationship between HDL-C and triglyceride concentrations. Accordingly, specimens with a low HDL-C often have a raised triglyceride concentration. HDL-C assay manufacturers often recommend dilution when the triglyceride is above a particular concentration. We decided to evaluate our routine HDL-C method to assess what triglyceride cut-off we should routinely utilise before specimen dilution.

HDL-C concentrations were determined using an anti human-ß-lipoprotein antibody that binds to non-HDL lipoproteins and allows the quantification of HDL-C by the presence . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.